FDA official logo
GSRS logo
PFDA official logo

BEVACIZUMAB

  • UNII: 2S9ZZM9Q9V
  • Preferred Substance Name: BEVACIZUMAB

  • 216974-75-3
  • 12-IGG1
  • ABP-215
  • ALYMSYS
  • AVA-1
  • AVASTIN
  • AVZIVI
  • BAT 1706 [WHO-DD]
  • BAT1706
  • BAT-1706
  • BAT-1706 (BIOSIMILAR OF BEVACIZUMAB)
  • BEVACIZUMAB (AVASTIN)
  • BEVACIZUMAB [EMA EPAR]
  • BEVACIZUMAB [INN]
  • BEVACIZUMAB [JAN]
  • BEVACIZUMAB [MART.]
  • BEVACIZUMAB [MI]
  • BEVACIZUMAB [PURPLE BOOK CDER]
  • BEVACIZUMAB [USAN]
  • BEVACIZUMAB [VANDF]
  • BEVACIZUMAB [WHO-DD]
  • BEVACIZUMAB AWWB [WHO-DD]
  • BEVACIZUMAB BETA
  • BEVACIZUMAB BETA [INN]
  • BEVACIZUMAB BETA [WHO-DD]
  • BEVACIZUMAB BIOSIMILAR - SHANGHAI HENLIUS BIOTECH
  • BEVACIZUMAB BIOSIMILAR (ABP-215)
  • BEVACIZUMAB BIOSIMILAR (AMGEN)
  • BEVACIZUMAB BIOSIMILAR (AMNEAL PHARMACEUTICALS)
  • BEVACIZUMAB BIOSIMILAR (CT-P16)
  • BEVACIZUMAB BIOSIMILAR (FKB-238)
  • BEVACIZUMAB BIOSIMILAR (GP-2019)
  • BEVACIZUMAB BIOSIMILAR (MABXIENCE)
  • BEVACIZUMAB BIOSIMILAR (PF-06439535)
  • BEVACIZUMAB BIOSIMILAR (PFIZER)
  • BEVACIZUMAB BIOSIMILAR-INNOVENT BIOLOGICS
  • BEVACIZUMAB BVZR [WHO-DD]
  • BEVACIZUMAB MALY [WHO-DD]
  • BEVACIZUMAB, LICENSE HOLDER UNSPECIFIED
  • BEVACIZUMAB-ADCD
  • BEVACIZUMAB-AWWB
  • BEVACIZUMAB-AWWB [PURPLE BOOK CDER]
  • BEVACIZUMAB-BVZR
  • BEVACIZUMAB-MALY
  • BEVACIZUMAB-TNJN
  • BEVAX
  • BEVZ92
  • BEVZ-92
  • BI 695502 [WHO-DD]
  • BI695502
  • BI-695502
  • BS-503
  • BS-503A
  • BYVASDA
  • CT16
  • CT-16
  • CTP16
  • CTP-16
  • CT-P16
  • CT-P16 (BIOSIMILAR OF BEVACIZUMAB)
  • FKB 238 [WHO-DD]
  • FKB238
  • FKB-238
  • GP2019
  • GP-2019
  • HLX 04 [WHO-DD]
  • HLX04
  • HLX-04
  • HLX04-O
  • HLX04-O (RECOMBINANT ANTI-VEGF HUMANIZED MONOCLONAL ANTIBODY OPHTHALMIC INJECTION)
  • IBI305
  • IBI-305
  • IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF .GAMMA.-CHAIN ANTI-HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL RHUMAB-VEGF LIGHT CHAIN, DIMER
  • LY 01008
  • LY 01008 [WHO-DD]
  • LY 01008(BIOSIMILAR OF BEVACIZUMAB)
  • LY-01008
  • MB02
  • MB-02
  • MVASI
  • OYAVAS
  • PF-06439535
  • PF-06439535 [WHO-DD]
  • Q1101
  • Q-1101
  • QL-1101 (BIOSIMILAR OF BEVACIZUMAB)
  • RG-435
  • RHUMAB-
  • RO-4876646
  • USP MAB 002, MONOCLONAL IGG1 [USP-RS]
  • VEGZELMA
  • ZIRABEV

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.




About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

Powered by

DNAnexus official logo